Home Pilots Karkinos Healthcare partners with US-based C2i Genomics to expand AI cancer detection Pilots Karkinos Healthcare partners with US-based C2i Genomics to expand AI cancer detection By - June 7, 2022 31 0 Facebook Twitter Pinterest WhatsApp They will provide the first access to an AI-enabled minimal residual disease test in India. RELATED ARTICLESMORE FROM AUTHOR Pilots Medtronic issues voluntary recall of MiniMed insulin pumps Pilots Hybrid primary care company Rezilient Health scores $10M Pilots Empathy Health Technologies raises $2.8M for Sober Sidekick app LEAVE A REPLY Cancel reply Please enter your comment! Please enter your name here You have entered an incorrect email address! Please enter your email address here Save my name, email, and website in this browser for the next time I comment. FOLLOW ME0FansLike0FollowersFollow0SubscribersSubscribe POPULAR ARTICLES Digital diagnostic company Everly Health names Anthem vet Dr. Liz Kwo as CMO Pilots - March 28, 2022 0 CVS Health to acquire Oak Street Health in $10.6B deal Pilots - February 8, 2023 0 Elon Musk’s Neuralink device Blindsight gets FDA breakthrough device designation Pilots - September 19, 2024 0 Google launches Fitbit Charge 6 with new health capabilities Pilots - September 28, 2023 0 UltraSight, Mayo Clinic develop Al-powered algorithms for image analysis Pilots - June 5, 2024 0 POPULAR CATEGORIESPilots2166Applications682Testing237Collaborations15GitHub3